Gain perspectives from experts on various policy issues and therapeutic areas through our Insights series that engages multiple managed care stakeholders in video interviews.

The Progression of Nr-AxSpA Symptoms
March 07, 2019 – 
Tiffany Westrich-Robertson considers the progression of her nonradiographic axial spondyloarthritis and how the worsening of her treatments have affected daily life.
Ineffective NrAxSpa Treatments
February 28, 2019 – 
Tiffany Westrich-Robertson provides insight into the various ineffective treatments she received prior to using the biologic therapy certolizumab pegol.
Living With Untreated NrAxSpa
February 28, 2019 – 
Tiffany Westrich-Robertson discusses the day-to-day difficulties and inhibitions of living with nonradiographic axial spondyloarthritis (NrAxSpa) prior to treatment of certolizumab pegol.
Timeline of NrAxSpa Onset to Correct Diagnosis
February 21, 2019 – 
Tiffany Westrich-Robertson provides an overview of the lengthy process involved in receiving proper treatment for nonradiographical axial spondyloarthritis in a time when NrAxSpa was little understood.
Initial Symptoms of NrAxSpa & Inconclusive Diagnostics
February 21, 2019 – 
Tiffany Westrich-Robertson considers her initial symptoms of nonradiographical axial spondyloarthritis (NrAxSpa) and discusses the difficulties of receiving proper treatment.
Axial Spondyloarthritis: Future Outlook
January 24, 2019 – 
Atul A. Deodhar, MD, reacts to emerging interest in axial spondyloarthritis and shares considerations for improving how the condition is managed in the future.
Treating Axial Spondyloarthritis
January 17, 2019 – 
Clinical expertise using various nonpharmacologic and pharmacologic therapies, including newer biologic agents, in the treatment of axial spondyloarthritis, and suggestions for ensuring treatment coverage to patients.
Clinical Recommendations: Managing Axial Spondyloarthritis
January 17, 2019 – 
An overview of current clinical guidelines and treatment recommendations for patients with axial spondyloarthritis, as well as a discussion on the potential importance of an early diagnosis and proper treatment and a patient’s risk for disease progression.
Establishing Goals of Therapy in Axial Spondyloarthritis
January 10, 2019 – 
Goals of therapy and considerations for using disease activity scores such as the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score (ASDAS) to assess and monitor patients.
Axial Spondyloarthritis and Quality of Life
January 10, 2019 – 
An expert in the management of axial spondyloarthritis explains how it differs from other rheumatologic conditions, highlights common comorbidities, and reacts to its overall burden on patients’ quality of life.
Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.